SME-3, a novel member of the Serratia marcescens SME family of carbapenem-hydrolyzing beta-lactamases

Antimicrob Agents Chemother. 2006 Oct;50(10):3485-7. doi: 10.1128/AAC.00363-06.

Abstract

Imipenem-resistant Serratia marcescens isolates were cultured from a lung transplant patient given multiple antibiotics over several months. The strains expressed SME-3, a beta-lactamase of the rare SME carbapenem-hydrolyzing family. SME-3 differed from SME-1 by a single amino acid substitution of tyrosine for histidine at position 105, but the two beta-lactamases displayed similar hydrolytic profiles.

MeSH terms

  • Anti-Bacterial Agents / metabolism
  • Anti-Bacterial Agents / pharmacology*
  • Carbapenems / metabolism*
  • Carbapenems / pharmacology
  • Humans
  • Imipenem / metabolism
  • Imipenem / pharmacology
  • Kinetics
  • Microbial Sensitivity Tests
  • Middle Aged
  • Serratia Infections / microbiology
  • Serratia marcescens / drug effects*
  • Serratia marcescens / enzymology*
  • beta-Lactam Resistance*
  • beta-Lactamases / classification
  • beta-Lactamases / genetics
  • beta-Lactamases / metabolism*

Substances

  • Anti-Bacterial Agents
  • Carbapenems
  • Imipenem
  • beta-Lactamases